New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Go back to New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
National Health Partners, Inc. (NYSE: HPR) Delayed: 4.73 --0 (-0%)
Previous Close $4.73    52 Week High $0.28 
Open $4.73    52 Week Low $0.25 
Day High $4.73    P/E N/A 
Day Low $4.73    EPS $-0.23 
Volume 308,342       

HORIZON PHARMA (NASDAQ: HZNP) Delayed: 92.56 -0.73 (0.78%)
Previous Close $93.29    52 Week High $23.44 
Open $93.41    52 Week Low $13.06 
Day High $94.01    P/E N/A 
Day Low $92.26    EPS $-0.96 
Volume 1,058,771